Supportive Care in Cancer, ISSN 0941-4355, 10/2019, Volume 27, Issue 10, pp. 3667 - 3679
Febrile neutropenia (FN) is an inflammatory response causing fever that may develop during cancer therapy-induced neutropenia. FN may herald life-threatening...
Pain Medicine | Nursing | Rehabilitation Medicine | Dental health | Cancer chemotherapy | Medicine & Public Health | Nursing Research | Oral infection | Oncology | Oral mucositis | Febrile neutropenia | ADJUVANT CHEMOTHERAPY | PRO-INFLAMMATORY CYTOKINES | ANAEROBIC BACTEREMIA | BONE-MARROW-TRANSPLANTATION | ONCOLOGY PATIENTS | HEMATOPOIETIC STEM-CELL | VIRIDANS STREPTOCOCCI | FUSOBACTERIUM-NUCLEATUM | PERIODONTAL INFECTION | ONCOLOGY | HEALTH CARE SCIENCES & SERVICES | DENTAL MANAGEMENT | REHABILITATION | Methicillin | Infection | Complications and side effects | Care and treatment | Chemotherapy | Development and progression | Inflammation | Vincristine | Cancer | Neutropenia | Review
Pain Medicine | Nursing | Rehabilitation Medicine | Dental health | Cancer chemotherapy | Medicine & Public Health | Nursing Research | Oral infection | Oncology | Oral mucositis | Febrile neutropenia | ADJUVANT CHEMOTHERAPY | PRO-INFLAMMATORY CYTOKINES | ANAEROBIC BACTEREMIA | BONE-MARROW-TRANSPLANTATION | ONCOLOGY PATIENTS | HEMATOPOIETIC STEM-CELL | VIRIDANS STREPTOCOCCI | FUSOBACTERIUM-NUCLEATUM | PERIODONTAL INFECTION | ONCOLOGY | HEALTH CARE SCIENCES & SERVICES | DENTAL MANAGEMENT | REHABILITATION | Methicillin | Infection | Complications and side effects | Care and treatment | Chemotherapy | Development and progression | Inflammation | Vincristine | Cancer | Neutropenia | Review
Journal Article
Malaria Journal, ISSN 1475-2875, 05/2019, Volume 18, Issue 1, pp. 186 - 8
Whole parasite vaccination is an efficacious strategy to induce sterile immunity and to prevent malaria transmission. Understanding the mechanism and response...
Malaria | Antibodies | Sporozoite | B cells | Whole parasite vaccine | Immunity | ELISpot | Prevention | Usage | Disease transmission | Malaria vaccine | Risk factors | Enzyme-linked immunosorbent assay | Immunoglobulin M | Endemic species | Peptides | Immunoglobulin G | Vaccination | Radiation | Transmission | Irradiated | Leukocytes (mononuclear) | Lymphocytes T | Infections | Vaccines | Parasites | Proteins | Seasonal variations | Sporozoites | Peripheral blood mononuclear cells | Dissection | Protection | Vector-borne diseases | Antigens | Human diseases | Immunoglobulins | Immunization | Disease control | Cells | Mosquitoes | Immunogenicity | Lymphocytes B | Frequency | Recombinants | Detection | Immunoassays
Malaria | Antibodies | Sporozoite | B cells | Whole parasite vaccine | Immunity | ELISpot | Prevention | Usage | Disease transmission | Malaria vaccine | Risk factors | Enzyme-linked immunosorbent assay | Immunoglobulin M | Endemic species | Peptides | Immunoglobulin G | Vaccination | Radiation | Transmission | Irradiated | Leukocytes (mononuclear) | Lymphocytes T | Infections | Vaccines | Parasites | Proteins | Seasonal variations | Sporozoites | Peripheral blood mononuclear cells | Dissection | Protection | Vector-borne diseases | Antigens | Human diseases | Immunoglobulins | Immunization | Disease control | Cells | Mosquitoes | Immunogenicity | Lymphocytes B | Frequency | Recombinants | Detection | Immunoassays
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 7/2007, Volume 196, Issue 1, pp. 145 - 154
Background. Challenge of volunteers by the bites of membrane-fed anopheline mosquitoes infected with Plasmodium falciparum was reported in 1986. In 1997, an...
Human experimentation | Polymerase chain reaction | Test ranges | Volunteerism | Malaria | Vaccination | Sporozoites | Parasites | Parasitemia | Symptoms | Blood | CELLS | INFECTIOUS DISEASES | EFFICACY | PROTECTION | MICROBIOLOGY | CANDIDATE | IMMUNOLOGY | VIRUS ANKARA | IMMUNIZATION | RESPONSES | IMMUNOGENICITY | MALARIA | CIRCUMSPOROZOITE PROTEIN VACCINE | Malaria, Falciparum - physiopathology | Malaria, Falciparum - drug therapy | Humans | Middle Aged | Male | Plasmodium falciparum - drug effects | Malaria, Falciparum - complications | Human Experimentation | Animals | Time Factors | Adolescent | Adult | Female | Insect Bites and Stings | Culicidae - parasitology | Plasmodium falciparum - growth & development | Safety | Plasmodium falciparum | Research | Patient outcomes
Human experimentation | Polymerase chain reaction | Test ranges | Volunteerism | Malaria | Vaccination | Sporozoites | Parasites | Parasitemia | Symptoms | Blood | CELLS | INFECTIOUS DISEASES | EFFICACY | PROTECTION | MICROBIOLOGY | CANDIDATE | IMMUNOLOGY | VIRUS ANKARA | IMMUNIZATION | RESPONSES | IMMUNOGENICITY | MALARIA | CIRCUMSPOROZOITE PROTEIN VACCINE | Malaria, Falciparum - physiopathology | Malaria, Falciparum - drug therapy | Humans | Middle Aged | Male | Plasmodium falciparum - drug effects | Malaria, Falciparum - complications | Human Experimentation | Animals | Time Factors | Adolescent | Adult | Female | Insect Bites and Stings | Culicidae - parasitology | Plasmodium falciparum - growth & development | Safety | Plasmodium falciparum | Research | Patient outcomes
Journal Article
Current Opinion in Infectious Diseases, ISSN 0951-7375, 10/2013, Volume 26, Issue 5, pp. 420 - 428
PURPOSE OF REVIEWThe whole sporozoite (SPZ) vaccine platform provides the only established approach for inducing high-level sustained protective immunity in...
genetically attenuated | vaccines | review | radiation attenuated | whole organism | sporozoite | malaria | INFECTIOUS DISEASES | STERILE IMMUNITY | FALCIPARUM | LIVER-STAGE | VIVAX MALARIA | IMMUNIZATION | RESPONSES | PROTECTIVE IMMUNITY | CD8+ T-CELLS | PLASMODIUM-BERGHEI | IRRADIATED SPOROZOITES | Malaria, Falciparum - prevention & control | Humans | Malaria - immunology | Plasmodium berghei - genetics | Plasmodium falciparum - immunology | Sporozoites - immunology | Malaria - prevention & control | Malaria, Falciparum - parasitology | Vaccines, Attenuated - immunology | Animals | Plasmodium falciparum - genetics | Malaria - parasitology | Malaria Vaccines - immunology | Malaria, Falciparum - immunology | Mice | Plasmodium berghei - microbiology | Malaria Vaccines - genetics
genetically attenuated | vaccines | review | radiation attenuated | whole organism | sporozoite | malaria | INFECTIOUS DISEASES | STERILE IMMUNITY | FALCIPARUM | LIVER-STAGE | VIVAX MALARIA | IMMUNIZATION | RESPONSES | PROTECTIVE IMMUNITY | CD8+ T-CELLS | PLASMODIUM-BERGHEI | IRRADIATED SPOROZOITES | Malaria, Falciparum - prevention & control | Humans | Malaria - immunology | Plasmodium berghei - genetics | Plasmodium falciparum - immunology | Sporozoites - immunology | Malaria - prevention & control | Malaria, Falciparum - parasitology | Vaccines, Attenuated - immunology | Animals | Plasmodium falciparum - genetics | Malaria - parasitology | Malaria Vaccines - immunology | Malaria, Falciparum - immunology | Mice | Plasmodium berghei - microbiology | Malaria Vaccines - genetics
Journal Article
Cancer, ISSN 0008-543X, 2014, Volume 120, Issue 10, pp. 1453 - 1461
BACKGROUND Mucositis is a highly significant, and sometimes dose-limiting, toxicity of cancer therapy. The goal of this systematic review was to update the...
gastrointestinal | mucositis | guidelines | oral | stomatitis | Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) | HEAD | GASTROINTESTINAL MUCOSITIS | ISOO | CELL TRANSPLANTATION | RANDOMIZED-TRIAL | ZINC SUPPLEMENTATION | NECK-CANCER | ONCOLOGY | MUCOSAL INJURY | ORAL MUCOSITIS | DOUBLE-BLIND | LEVEL LASER THERAPY | Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC | Sucralfate - administration & dosage | Humans | Radiotherapy - adverse effects | Antineoplastic Agents - administration & dosage | Protective Agents - therapeutic use | Mucositis - prevention & control | Proctitis - prevention & control | Antineoplastic Agents - adverse effects | Anti-Inflammatory Agents - therapeutic use | Neoplasms - radiotherapy | Intercellular Signaling Peptides and Proteins - administration & dosage | Low-Level Light Therapy | Esophagitis - therapy | Analgesics - therapeutic use | Proctitis - therapy | Anti-Infective Agents - therapeutic use | Evidence-Based Medicine | Mucositis - therapy | Cytokines - administration & dosage | Esophagitis - etiology | Stomatitis - etiology | Mucositis - chemically induced | Oral Hygiene | Anti-Ulcer Agents - administration & dosage | Neoplasms - drug therapy | Phototherapy | Stomatitis - therapy | Proctitis - etiology | Mucositis - etiology | Stomatitis - chemically induced | Esophagitis - prevention & control | Radiation-Protective Agents - therapeutic use | Stomatitis - prevention & control | Amifostine - therapeutic use | Cryotherapy | Hyperbaric Oxygenation | Practice guidelines (Medicine) | Usage | Care and treatment | Mucositis | Analysis | Cancer | Index Medicus | Abridged Index Medicus | Review
gastrointestinal | mucositis | guidelines | oral | stomatitis | Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) | HEAD | GASTROINTESTINAL MUCOSITIS | ISOO | CELL TRANSPLANTATION | RANDOMIZED-TRIAL | ZINC SUPPLEMENTATION | NECK-CANCER | ONCOLOGY | MUCOSAL INJURY | ORAL MUCOSITIS | DOUBLE-BLIND | LEVEL LASER THERAPY | Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC | Sucralfate - administration & dosage | Humans | Radiotherapy - adverse effects | Antineoplastic Agents - administration & dosage | Protective Agents - therapeutic use | Mucositis - prevention & control | Proctitis - prevention & control | Antineoplastic Agents - adverse effects | Anti-Inflammatory Agents - therapeutic use | Neoplasms - radiotherapy | Intercellular Signaling Peptides and Proteins - administration & dosage | Low-Level Light Therapy | Esophagitis - therapy | Analgesics - therapeutic use | Proctitis - therapy | Anti-Infective Agents - therapeutic use | Evidence-Based Medicine | Mucositis - therapy | Cytokines - administration & dosage | Esophagitis - etiology | Stomatitis - etiology | Mucositis - chemically induced | Oral Hygiene | Anti-Ulcer Agents - administration & dosage | Neoplasms - drug therapy | Phototherapy | Stomatitis - therapy | Proctitis - etiology | Mucositis - etiology | Stomatitis - chemically induced | Esophagitis - prevention & control | Radiation-Protective Agents - therapeutic use | Stomatitis - prevention & control | Amifostine - therapeutic use | Cryotherapy | Hyperbaric Oxygenation | Practice guidelines (Medicine) | Usage | Care and treatment | Mucositis | Analysis | Cancer | Index Medicus | Abridged Index Medicus | Review
Journal Article
Science, ISSN 0036-8075, 9/2013, Volume 341, Issue 6152, pp. 1359 - 1365
Consistent high-level, vaccine-induced protection against human malaria has only been achieved by inoculation of Plasmodium falciparum (Pf) sporozoites (SPZ)...
T lymphocytes | Antigens | Patents | Immunization | RESEARCH ARTICLE | Malaria | Intravenous injections | Vaccination | Sporozoites | Antibodies | Dosage | ANTIBODIES | TRIAL | IMMUNITY | CD8+ T-CELLS | EFFICACY | LIVER STAGES | MULTIDISCIPLINARY SCIENCES | MICE | PLASMODIUM-FALCIPARUM MALARIA | CIRCUMSPOROZOITE PROTEIN VACCINE | Malaria, Falciparum - prevention & control | Humans | Male | Plasmodium falciparum - immunology | Vaccination - adverse effects | Sporozoites - immunology | Administration, Intravenous | Animals | Malaria Vaccines - administration & dosage | Vaccination - methods | Malaria Vaccines - adverse effects | Malaria Vaccines - immunology | Adult | Female | T-Lymphocytes - immunology | Mice | Immunity, Cellular | Cytokines - immunology | Prevention | Intravenous therapy | Sporozoa | Health aspects | Risk factors | Methods | Monoclonal antibodies | Vaccines | Immune system | Medical research | Cellular | Correlation | Attenuation | Parasites
T lymphocytes | Antigens | Patents | Immunization | RESEARCH ARTICLE | Malaria | Intravenous injections | Vaccination | Sporozoites | Antibodies | Dosage | ANTIBODIES | TRIAL | IMMUNITY | CD8+ T-CELLS | EFFICACY | LIVER STAGES | MULTIDISCIPLINARY SCIENCES | MICE | PLASMODIUM-FALCIPARUM MALARIA | CIRCUMSPOROZOITE PROTEIN VACCINE | Malaria, Falciparum - prevention & control | Humans | Male | Plasmodium falciparum - immunology | Vaccination - adverse effects | Sporozoites - immunology | Administration, Intravenous | Animals | Malaria Vaccines - administration & dosage | Vaccination - methods | Malaria Vaccines - adverse effects | Malaria Vaccines - immunology | Adult | Female | T-Lymphocytes - immunology | Mice | Immunity, Cellular | Cytokines - immunology | Prevention | Intravenous therapy | Sporozoa | Health aspects | Risk factors | Methods | Monoclonal antibodies | Vaccines | Immune system | Medical research | Cellular | Correlation | Attenuation | Parasites
Journal Article
Journal of Oncology Practice, ISSN 1554-7477, 12/2018, Volume 14, Issue 12, pp. E775 - E785
Background Prior work to integrate early palliative care in oncology has focused on patients with advanced cancer and primarily on palliative care...
OF-LIFE CARE | HOSPICE | COST | MALIGNANCY | INTEGRATION | ONCOLOGY | CONSULTATION | OUTCOMES | CHEMOTHERAPY | ACCESS | PERCEPTIONS | Humans | Middle Aged | Male | Palliative Care | Gastrointestinal Neoplasms - therapy | Myelodysplastic Syndromes - epidemiology | Ambulatory Care | Gastrointestinal Neoplasms - pathology | Myelodysplastic Syndromes - therapy | Gastrointestinal Neoplasms - epidemiology | Clinical Decision-Making | Medical Oncology - trends | Aged, 80 and over | Adult | Female | Aged | Myelodysplastic Syndromes - pathology
OF-LIFE CARE | HOSPICE | COST | MALIGNANCY | INTEGRATION | ONCOLOGY | CONSULTATION | OUTCOMES | CHEMOTHERAPY | ACCESS | PERCEPTIONS | Humans | Middle Aged | Male | Palliative Care | Gastrointestinal Neoplasms - therapy | Myelodysplastic Syndromes - epidemiology | Ambulatory Care | Gastrointestinal Neoplasms - pathology | Myelodysplastic Syndromes - therapy | Gastrointestinal Neoplasms - epidemiology | Clinical Decision-Making | Medical Oncology - trends | Aged, 80 and over | Adult | Female | Aged | Myelodysplastic Syndromes - pathology
Journal Article
American Journal of Tropical Medicine and Hygiene, ISSN 0002-9637, 01/2013, Volume 88, Issue 1, pp. 3 - 4
SPOROZOITE INOCULATION | CHALLENGE | IMMUNIZATION | IMMUNITY | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PROTECTION | MOSQUITOS | EFFICACY | PLASMODIUM-FALCIPARUM | ATOVAQUONE | HUMAN VOLUNTEERS | TROPICAL MEDICINE | Animals | Malaria, Falciparum - therapy | Plasmodium falciparum - growth & development | Humans | Sporozoites
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 2016, Volume 24, Issue 6, pp. 2793 - 2805
Purpose There is a large body of evidence supporting the efficacy of low-level laser therapy (LLLT), more recently termed photobiomodulation (PBM) for the...
Orofacial complications | Rehabilitation Medicine | Low-level light therapy | Mucositis | Photobiomodulation | Oncology | Radiation therapy | LLLT | Nursing Management/Nursing Research | Low-level laser therapy | Pain Medicine | Chemotherapy | Nursing | Medicine & Public Health | Head and neck cancer | PBM | BISPHOSPHONATE-INDUCED OSTEONECROSIS | SALIVARY-GLAND HYPOFUNCTION | RANDOMIZED CONTROLLED-TRIAL | CLINICAL-PRACTICE GUIDELINES | BREAST-CANCER | INDUCED ORAL MUCOSITIS | RADIATION DERMATITIS | ONCOLOGY | HEALTH CARE SCIENCES & SERVICES | REHABILITATION | QUALITY-OF-LIFE | SWALLOWING DYSFUNCTION | CONCURRENT CHEMORADIOTHERAPY | Head and Neck Neoplasms - radiotherapy | Chemoradiotherapy - adverse effects | Low-Level Light Therapy - methods | Humans | Clinical Protocols | Head and Neck Neoplasms - drug therapy | Head and Neck Neoplasms - therapy | Drug-Related Side Effects and Adverse Reactions - etiology | Drug-Related Side Effects and Adverse Reactions - therapy | Complications and side effects | Evidence, Expert | Care and treatment | Lasers in surgery | Light-emitting diodes | Patient compliance | Cancer | Lasers in medicine | Side effects | Head & neck cancer | Lasers
Orofacial complications | Rehabilitation Medicine | Low-level light therapy | Mucositis | Photobiomodulation | Oncology | Radiation therapy | LLLT | Nursing Management/Nursing Research | Low-level laser therapy | Pain Medicine | Chemotherapy | Nursing | Medicine & Public Health | Head and neck cancer | PBM | BISPHOSPHONATE-INDUCED OSTEONECROSIS | SALIVARY-GLAND HYPOFUNCTION | RANDOMIZED CONTROLLED-TRIAL | CLINICAL-PRACTICE GUIDELINES | BREAST-CANCER | INDUCED ORAL MUCOSITIS | RADIATION DERMATITIS | ONCOLOGY | HEALTH CARE SCIENCES & SERVICES | REHABILITATION | QUALITY-OF-LIFE | SWALLOWING DYSFUNCTION | CONCURRENT CHEMORADIOTHERAPY | Head and Neck Neoplasms - radiotherapy | Chemoradiotherapy - adverse effects | Low-Level Light Therapy - methods | Humans | Clinical Protocols | Head and Neck Neoplasms - drug therapy | Head and Neck Neoplasms - therapy | Drug-Related Side Effects and Adverse Reactions - etiology | Drug-Related Side Effects and Adverse Reactions - therapy | Complications and side effects | Evidence, Expert | Care and treatment | Lasers in surgery | Light-emitting diodes | Patient compliance | Cancer | Lasers in medicine | Side effects | Head & neck cancer | Lasers
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 2016, Volume 24, Issue 6, pp. 2781 - 2792
There is a large body of evidence supporting the efficacy of low level laser therapy (LLLT), more recently termed photobiomodulation (PBM), for the management...
Orofacial complications | Rehabilitation Medicine | Mucositis | Low level light therapy | Photobiomodulation | Oncology | Radiation therapy | Nursing Management/Nursing Research | Pain Medicine | Chemotherapy | Nursing | Medicine & Public Health | LLLT and PBM | Head and neck cancer | Low level laser therapy | Safety | TGF-BETA | LIGHT THERAPY | TUMOR-CELLS | FIBROBLAST PROLIFERATION | CYTOCHROME-C-OXIDASE | IN-VITRO | BIPHASIC DOSE-RESPONSE | ONCOLOGY | ORAL MUCOSITIS | HEALTH CARE SCIENCES & SERVICES | SQUAMOUS-CELL CARCINOMA | REHABILITATION | TISSUES HARBORING CANCER | Head and Neck Neoplasms - radiotherapy | Chemoradiotherapy - adverse effects | Low-Level Light Therapy - adverse effects | Low-Level Light Therapy - methods | Low-Level Light Therapy - standards | Humans | Head and Neck Neoplasms - drug therapy | Head and Neck Neoplasms - therapy | Drug-Related Side Effects and Adverse Reactions - etiology | Drug-Related Side Effects and Adverse Reactions - therapy | Complications and side effects | Lasers in surgery | Analysis | Radiation | Radiotherapy | Lasers in medicine | Cancer | Side effects | Oral diseases | Head & neck cancer | Lasers
Orofacial complications | Rehabilitation Medicine | Mucositis | Low level light therapy | Photobiomodulation | Oncology | Radiation therapy | Nursing Management/Nursing Research | Pain Medicine | Chemotherapy | Nursing | Medicine & Public Health | LLLT and PBM | Head and neck cancer | Low level laser therapy | Safety | TGF-BETA | LIGHT THERAPY | TUMOR-CELLS | FIBROBLAST PROLIFERATION | CYTOCHROME-C-OXIDASE | IN-VITRO | BIPHASIC DOSE-RESPONSE | ONCOLOGY | ORAL MUCOSITIS | HEALTH CARE SCIENCES & SERVICES | SQUAMOUS-CELL CARCINOMA | REHABILITATION | TISSUES HARBORING CANCER | Head and Neck Neoplasms - radiotherapy | Chemoradiotherapy - adverse effects | Low-Level Light Therapy - adverse effects | Low-Level Light Therapy - methods | Low-Level Light Therapy - standards | Humans | Head and Neck Neoplasms - drug therapy | Head and Neck Neoplasms - therapy | Drug-Related Side Effects and Adverse Reactions - etiology | Drug-Related Side Effects and Adverse Reactions - therapy | Complications and side effects | Lasers in surgery | Analysis | Radiation | Radiotherapy | Lasers in medicine | Cancer | Side effects | Oral diseases | Head & neck cancer | Lasers
Journal Article